NCT02361996 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Rienmüller T, Baumgartner C, Handler M, Makarenko V, Ourednicek P, Krestinich IM, Zhorzholiani ST, Rienmüller R, Bockeria L
Quantitative Estimation of Left Ventricular Myocardial Perfusion Based on Dynamic CT Scans. Biomed Tech (Berl). 2013 Aug;58 Suppl 1. pii: /j/bmte.2013.58.issue-s1-L/bmt-2013-4288/bmt-2013-4288.xml. doi: 10.1515/bmt-2013-4288. Epub 2013 Sep 7.

Quantitative Measurement of Myocardial Perfusion by Cardiac CT in Patients Before and After Coronary-bypass-surgery, Before and After Dilating/Stenting and Before and After Aortic-valve-replacement.

Details for clinical trial NCT02361996

Clinical trial NCT02361996 - References